Blumrich M, Petzinger E
Institute of Pharmacology and Toxicology, Justus Liebig University Giessen, Germany.
Biochim Biophys Acta. 1993 Jul 4;1149(2):278-84. doi: 10.1016/0005-2736(93)90211-h.
Substances that block SH-groups were studied in respect to their effects on the uptake of the loop diuretic bumetanide and the bile acids cholate and taurocholate into isolated rat hepatocytes. SH-blockers, e.g., p-chloromercuribenzenesulfonate (PCMBS), N-ethylmaleimide (NEM), dithiobis-nitropyridine (DTNP) and dithiobis-2-nitrobenzoic acid (DTNB) reduced bumetanide transport in a concentration-dependent manner. Inhibition of the organic mercurial PCMBS was reversed by the addition of 500 microM dithiothreitol (DTT), indicating an interaction of this substance with free SH-groups. NEM irreversibly blocked SH-groups by covalent binding and was the most effective inhibitor of bumetanide and cholate uptake. In contrast, PCMBS was the most effective inhibitor of taurocholate uptake. Photoaffinity studies with [3H]bumetanide and [3H]7,7-azotaurocholate were performed with isolated rat hepatocytes in the presence of PCMBS and DTNP. Binding of the photolabels was not reduced by SH-group blockers. Newly synthesized sulfhydryl-modifying reagents such as dithio-sulfonate-ethyl-nitrobenzoic acid (DTSNB) and dithio-octyl-nitrobenzoic acid (DTONB), are derivatives of the alkylating agent DTNB. DTSNB is regarded as a selective blocker for SH-groups in a hydrophilic environment, while DTONB is more lipophilic abd interacts with SH-groups in the transmembrane domain of transport proteins. The IC50-values of these blockers for bumetanide uptake (DTSNB 250 microM, DTONB 141 microM) and for cholate uptake (DTSNB 250 microM, DTONB 115 microM) were almost identical. These findings support the concept of a common uptake mechanism for cholate and bumetanide and indicate that two distinct moieties of SH-groups are required for the uptake of both organic anions. One of these is probably located on the outer surface and the other within the membrane of hepatocytes.
研究了能阻断巯基的物质对髓袢利尿剂布美他尼以及胆汁酸胆酸盐和牛磺胆酸盐进入分离的大鼠肝细胞的影响。巯基阻断剂,如对氯汞苯磺酸盐(PCMBS)、N-乙基马来酰亚胺(NEM)、二硫代双硝基吡啶(DTNP)和二硫代双-2-硝基苯甲酸(DTNB),以浓度依赖的方式降低布美他尼的转运。加入500微摩尔二硫苏糖醇(DTT)可逆转有机汞PCMBS的抑制作用,表明该物质与游离巯基相互作用。NEM通过共价结合不可逆地阻断巯基,是布美他尼和胆酸盐摄取最有效的抑制剂。相比之下,PCMBS是牛磺胆酸盐摄取最有效的抑制剂。在PCMBS和DTNP存在的情况下,用分离的大鼠肝细胞对[3H]布美他尼和[3H]7,7-偶氮牛磺胆酸盐进行了光亲和研究。巯基阻断剂不会降低光标记物的结合。新合成的巯基修饰试剂,如二硫代磺酸乙酯硝基苯甲酸(DTSNB)和二硫代辛基硝基苯甲酸(DTONB),是烷基化剂DTNB的衍生物。DTSNB被认为是亲水环境中巯基的选择性阻断剂,而DTONB具有更强的亲脂性,可与转运蛋白跨膜结构域中的巯基相互作用。这些阻断剂对布美他尼摄取的半数抑制浓度值(DTSNB为250微摩尔,DTONB为|41微摩尔)和对胆酸盐摄取的半数抑制浓度值(DTSNB为250微摩尔,DTONB为115微摩尔)几乎相同。这些发现支持了胆酸盐和布美他尼存在共同摄取机制的概念,并表明两种有机阴离子的摄取需要两个不同的巯基部分。其中一个可能位于肝细胞外表面,另一个位于肝细胞膜内。